Active Shortage

APO-QUINAPRIL

APOTEX INC

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of APO-QUINAPRIL in Canada?

Yes. APO-QUINAPRIL 20MG has an active shortage reported to Health Canada (last updated December 3, 2021).

Why is APO-QUINAPRIL not available?

The reason the manufacturer reported: Shortage of an active ingredient.

When will APO-QUINAPRIL be available again?

No estimated resolution date has been reported yet. Follow this page to get an email as soon as the status changes.

Can I still get this?Possibly — same-ingredient product records found

StatusActive Shortage

Same-ingredient products on file2 products

Affected strength20MG

Last updated2021-12-03

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Closest Matches

TARO-QUINAPRIL

SUN PHARMA CANADA INC

20MG · DIN 02299771

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

Other Products

PMS-QUINAPRIL

PHARMASCIENCE INC

10MG · DIN 02340569

Different strengthSame dosage formSame routeNo current shortage

Compare these two →

What this means

Does this mean my pharmacy is out of stock?

Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.

What should I do?

Contact your pharmacy before your current supply runs low, and ask your pharmacist about next steps if they're out.

DIN

02248501

Strength

20MG

Dosage Form

TABLET

Route

ORAL

Active Ingredient

QUINAPRIL

See all QUINAPRIL products →

Compare with another product →

Product Monograph

Official Product Monograph (Health Canada)

View official Health Canada drug record ↗

Shortage Timeline

Approximate — based on the dates HPSC reports were last updated, not confirmed onset or resolution dates. Gaps between bars are periods with no shortage on file.

Active/anticipated Resolved

Shortage History

2021-12-03

Active Shortage

Shortage of an active ingredient.

Other Products from APOTEX INC

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

24HR NASAL ALLERGY RELIEF

50MCG · DIN 02460513

ACETAMINOPHEN CAPLETS 325 MG

325MG · DIN 02362341

ACETAMINOPHEN CAPLETS 500 MG

500MG · DIN 02362368

ACETAMINOPHEN HEADACHE ULTRA RELIEF

DIN 02290901

ACETAMINOPHEN TABLETS USP 325 MG

325MG · DIN 02362422

ACETAMINOPHEN TABLETS USP 500 MG

500MG · DIN 02362244